Article
Dorado, Puerto Rico-Have you ever wondered what you as a cataract surgeon can do to improve your patients' outcomes? Steve A. Arshinoff, MD, FRCSC, may have some answers.
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
(EyePod) From idea to impact: Navigating ophthalmic innovation
Study explores the true costs of treating pediatric cataracts
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery
Raising cataract surgery procedure to an art and an experience